C4 Therapeutics (C4T) is a clinical-stage biotechnology company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. They are leveraging their TORPEDO® platform to rapidly and efficiently design and optimize small-molecule medicines that harness the body’s natural protein recycling system…More to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. They are advancing multiple targeted oncology programs to the clinic and expanding their research platform to deliver the next wave of medicines for difficult-to-treat diseases.
C4 Therapeutics, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.
Shipping Information
Please fill out the form below and click "Place Order" to complete your order.